Skip to content
The Policy VaultThe Policy Vault

SyndrosMedica

Nausea and vomiting associated with cancer chemotherapy

Preferred products

  • generic dronabinol capsules

Initial criteria

  • Approve for 1 year if BOTH of the following:
  • A) Patient has failed to respond adequately to at least TWO conventional antiemetic treatments; AND
  • B) ONE of the following:
  • i. Patient has tried generic dronabinol capsules; OR
  • ii. Patient cannot swallow or has difficulty swallowing capsules.

Approval duration

1 year